Tig Advisors, LLC Neurocrine Biosciences Inc Transaction History
Tig Advisors, LLC
- $1.53 Billion
- Q3 2024
A detailed history of Tig Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Tig Advisors, LLC holds 92,100 shares of NBIX stock, worth $11.3 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
92,100Holding current value
$11.3 Million% of portfolio
1.51%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.3MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.74 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$631 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$316 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$229 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...